Ori Biotech, a leader in cell and gene therapy (CGT) manufacturing technologies, and the Cell Therapy Manufacturing Center (CTMC), a joint venture between National Resilience Inc. and MD Anderson Cancer Center, have entered a collaborative partnership to develop industrial manufacturing processes for cell therapies.   The partnership will accelerate process development, clinical implementation, and commercialization of novel cell therapies. Furthermore, it will combine Ori’s technology platfor...